top of page
color cloud.png
Michael Mithoefer
no pic.jpg
no pic.jpg

Michael Mithoefer

MAPS PBC
USA

Michael Mithoefer, M.D., is a psychiatrist living in Asheville, NC, with a research office in Charleston, SC. He and his wife, Annie, conducted the first US Phase 2 clinical trial of MDMA-assisted Psychotherapy and subsequent Phase 2 trials. As well a study providing MDMA-assisted sessions for therapists who have completed the MAPS Therapist Training, and a pilot study treating couples with MDMA-assisted psychotherapy combined with Cognitive Behavioral Conjoint Therapy. He is now a Senior Medical Director at MAPS Public Benefit Corporation (MPBC). He is a Grof-certified Holotropic Breathwork Facilitator, is trained in EMDR and Internal Family Systems Therapy, and has nearly 30 years experience treating trauma patients. Before going into psychiatry in 1991 he practiced emergency medicine for ten years. He has been board certified in Psychiatry, Emergency Medicine, and Internal Medicine, and is a Fellow of the American Psychiatric Association, and Affiliate Assistant Professor Department of Psychiatry and Behavioral Sciences Medical University of South Carolina.

color cloud.png

Stay Up to Date

Never miss a deadline. Get the latest to your inbox. 

Thanks for subscribing!

About Psychedelic Medicine – Israel 2026

With the rediscovery of psychedelic drugs as potential treatments for psychiatric disorders, we may be on the verge of the next revolution. The potential impact of psychedelics is not limited to psychiatry. Fields such as neurology, palliative care, addiction and pain medicine are among the potential beneficiaries along with inflammatory and possibly autoimmune disorders. 

Conference Organizer
comtec_med.jpg
bottom of page